These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 27397599

  • 1. Influence of Adrenalectomy on Protective Effects of Urocortin I, a Corticotropin-Releasing Factor, Against Indomethacin-Induced Enteropathy in Rats.
    Takeuchi K, Abe N, Kumano A.
    Curr Neuropharmacol; 2016; 14(8):866-875. PubMed ID: 27397599
    [Abstract] [Full Text] [Related]

  • 2. Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.
    Kubo Y, Kumano A, Kamei K, Amagase K, Abe N, Takeuchi K.
    Dig Dis Sci; 2010 Jun; 55(6):1570-80. PubMed ID: 19707872
    [Abstract] [Full Text] [Related]

  • 3. Involvement of corticotropin-releasing factor and corticotropin-releasing factor 2 receptors in pathogenesis of ischemia/reperfusion-induced enteritis in rats.
    Takeuchi K, Kumano A, Abe N, Kotani T.
    J Physiol Pharmacol; 2016 Oct; 67(5):697-707. PubMed ID: 28011950
    [Abstract] [Full Text] [Related]

  • 4. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats.
    Takeuchi K, Miyazawa T, Tanaka A, Kato S, Kunikata T.
    Digestion; 2002 Oct; 66(1):30-41. PubMed ID: 12379813
    [Abstract] [Full Text] [Related]

  • 5. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
    Takeuchi K, Yokota A, Tanaka A, Takahira Y.
    Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sildenafil, an inhibitor of phosphodiesterase subtype 5, prevents indomethacin-induced small-intestinal ulceration in rats via a NO/cGMP-dependent mechanism.
    Kato N, Mashita Y, Kato S, Mitsufuji S, Yoshikawa T, Takeuchi K.
    Dig Dis Sci; 2009 Nov; 54(11):2346-56. PubMed ID: 19101800
    [Abstract] [Full Text] [Related]

  • 8. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
    Yoda Y, Amagase K, Kato S, Tokioka S, Murano M, Kakimoto K, Nishio H, Umegaki E, Takeuchi K, Higuchi K.
    J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
    [Abstract] [Full Text] [Related]

  • 9. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
    Miyazawa T, Matsumoto M, Kato S, Takeuchi K.
    Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.
    Kamei K, Kubo Y, Kato N, Hatazawa R, Amagase K, Takeuchi K.
    Dig Dis Sci; 2008 Oct; 53(10):2657-66. PubMed ID: 18306037
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats.
    Nishio H, Hayashi Y, Terashima S, Takeuchi K.
    Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018
    [Abstract] [Full Text] [Related]

  • 12. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
    Tanaka A, Mizoguchi H, Hase S, Miyazawa T, Takeuchi K.
    Med Sci Monit; 2001 Dec; 7(5):869-77. PubMed ID: 11535926
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D₂-receptor antagonists ameliorate indomethacin-induced small intestinal ulceration in mice by activating α7 nicotinic acetylcholine receptors.
    Yasuda M, Kawahara R, Hashimura H, Yamanaka N, Iimori M, Amagase K, Kato S, Takeuchi K.
    J Pharmacol Sci; 2011 Dec; 116(3):274-82. PubMed ID: 21691039
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
    Yin Y, Dong L, Yin D.
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e79-87. PubMed ID: 17944898
    [Abstract] [Full Text] [Related]

  • 17. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats.
    Konaka A, Kato S, Tanaka A, Kunikata T, Korolkiewicz R, Takeuchi K.
    Pharmacol Res; 1999 Dec; 40(6):517-24. PubMed ID: 10660951
    [Abstract] [Full Text] [Related]

  • 18. Protection by aspirin of indomethacin-induced small intestinal damage in rats: mediation by salicylic acid.
    Takeuchi K, Hase S, Mizoguchi H, Komoike Y, Tanaka A.
    J Physiol Paris; 2001 Dec; 95(1-6):51-7. PubMed ID: 11595418
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
    Tanaka A, Matsumoto M, Hayashi Y, Takeuchi K.
    J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.